Analyst Expectations for Avadel Pharmaceuticals's Future
Portfolio Pulse from Benzinga Insights
In the last quarter, Avadel Pharmaceuticals (NASDAQ:AVDL) received 6 bullish and 2 somewhat bullish ratings from analysts. Over the past 3 months, 8 analysts have offered 12-month price targets for the company, with an average price target of $20.12, a high of $25.00, and a low of $18.00. The average price target has increased by 12.84% over the past month.
August 10, 2023 | 1:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Avadel Pharmaceuticals has received positive analyst ratings, which could boost investor confidence and potentially drive the stock price up in the short term.
Analyst ratings often influence investor sentiment and can impact a company's stock price. In this case, Avadel Pharmaceuticals has received predominantly bullish ratings, which indicates a positive outlook for the company's stock. This could lead to increased investor confidence and a potential rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100